Trial Profile
A Phase I/II Single-Centre Double-Blinded Randomized Study of the Safety and Tolerability of TMC120 Vaginal Microbicide Gel Vs. HEC-Based Universal Placebo Gel in Healthy HIV-Negative Women.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Sep 2009
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors International Partnership for Microbicides
- 31 Jul 2009 Results have been reported in AIDS.
- 21 Nov 2006 New trial record.